MAO is a possible Alzheimer's disease biomarker
Alzheimer's disease affects more than 35 million people, a number that is expected to increase in the coming years. Currently, Alzheimer's diagnoses rely on clinical neuropathologic assessment of amyloid-β (Aβ) peptide ...
Dec 7, 2016
0
2